Examines the lack of support for the training and employment of clinical investigators to capitalize on the knowledge gleaned from decades of basic scientific research. Argues that this dilemma can be addressed by carefully defining and marshalling a coalition of institutions to support increased funding for clinical investigations. (MDM)

Despite key changes in the federal Acquired Immune Deficiency Syndrome (AIDS) research program, activists and some scientists are frustrated that not enough has been done and the actions taken have not had sufficient impact on the problem. Controversy over basic vs. clinical-trial research persists. (MSE)

The scientific community's expectations for biomedical research exceed funding capacity. Despite national social and economic problems, funding for biomedical research is already high. Additional funds will not solve the problem entirely. The biomedical community must set priorities and allocate money accordingly. New policies for allocating funds…

Summarizes and comments on three presentations relative to the life sciences and medicine given at the October 1995 working symposium of the Project on Conflict of Interest in University-Industry Research Relationships and included in this issue. Discusses the work of medical researcher David Blumenthal, political scientist Mark Frankel, and…

This report provides an overview of Minnesota's Medical Education and Research Costs (MERC) project, which was undertaken to gather data on the costs of medical education and health care research conducted by hospitals, medical centers, and health maintenance organizations and to develop mechanisms to assess the costs across the health care…

Some problems in the changing pattern of relationships between bedside teaching, clinical research, and provision of medical services in academic hospitals are examined, including patient types, sophistication of medical intervention, and specialization. Four elements of government policy that might favor desirable development in these areas are…

Several recent, substantial reports are examined that, taken together, point the way toward a constructive reformulation of health sciences policy. Private, public, and Congressional reports suggest the high quality of the bioscience effort as well as the need to broaden traditional concepts to include centrally the sciences associated with public…

The president of the American Association of Colleges of Pharmacy outlines the association's position on national policy concerning health care reform, then looks at some related controversial issues, including changes in the dispensing of prescriptions, pharmacist-managed medication review, adequacy of pharmacy training, and the role of research.…

This report discusses the activities of Minnesota's Medical Education and Research Costs (MERC) project, which was undertaken to gather data on the costs of medical education and health care research conducted by hospitals, medical centers, and health maintenance organizations and to develop mechanisms to assess the costs across the health care…

This final report discusses the activities of Minnesota's Medical Education and Research Costs (MERC) project, which was undertaken to gather data on the costs of medical education and health care research conducted by hospitals, medical centers, and health maintenance organizations and develop mechanisms to assess the costs across the health care…

Foresight analysis is proposed as an alternative to strategic planning in the scientific community, and its use by individual funding agencies to develop research resource allocation strategies for specific scientific fields is explored through an analysis in the field of cardiovascular research. Methodology is explained, and preliminary results…

Portuguese legislative and policy moves since 1974 and their effects on academic hospitals are chronicled. The changes began with a serious university crisis, through which academic hospitals were abolished, and have resulted in legislation offering the potential for a restructuring of medical training and research. (Author/MSE)

Three principal aspects of capital needs in biomedical research are discussed: the significant and growing need for capital; sources; and the role of federal policy. Important assumptions, questions, and possible future trends are discussed. Consolidated thinking and effort are encouraged. (MSE)

With an estimated 17-22 million animals used in laboratories annually in the United States, public interest in animal welfare has sparked an often emotional debate over such uses of animals. Concerns focus on balancing societal needs for continued progress in biomedical and behavioral research, for toxicity testing to safeguard the public, and for…

A policy statement drafted by the Association of American Medical Colleges is presented that reviews the goals, environment, and mechanisms of support of biomedical and behavioral research.